An increased expression of the COPD related cytokines G-CSF, KC and TNF-α was seen in lung homogenate (Fig. 6G and H) and BALF (Fig. 6I and J) in the LPS group, which was decreased substantially by the RCD405 treatment. The gene discussed is CSF3; the disease is chronic obstructive pulmonary disease.